Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Sep 30, 2025 | (FY)Jun 30, 2025 | (Q4)Jun 30, 2025 | (Q3)Mar 31, 2025 | (Q2)Dec 31, 2024 | (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 44.72%-23.26K | -26.22%149.1K | -87.13%20.93K | -84.33%68.14K | 1,507.19%102.11K | 89.52%-42.08K | 224.03%202.09K | 294.54%162.64K | 1,296.31%434.78K | -71.09%6.35K |
| Net income from continuing operations | -123.63%-20.55K | 33.08%-343.11K | 23.65%-479.53K | -100.53%-346 | -47.40%49.81K | 293.45%86.95K | 50.26%-512.74K | 27.22%-628.05K | 191.48%65.55K | 224.84%94.71K |
| Operating gains losses | ---- | --114.01K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization | -25.60%10.31K | 388.31%370.69K | 833.96%304.43K | -50.19%17.53K | 329.08%34.88K | --13.86K | 498.53%75.91K | 205.37%32.6K | 11,106.69%35.19K | 1,722.42%8.13K |
| Asset impairment expenditure | ---- | --0 | ---- | ---- | ---- | ---- | -24.74%560.73K | ---- | ---- | ---- |
| Remuneration paid in stock | ---- | --0 | ---- | ---- | ---- | ---- | --126.52K | ---- | ---- | ---- |
| Other non cashItems | 15.48%813 | -0.40%2.75K | -52.07%615 | 46.03%717 | 44.60%710 | 43.09%704 | 46.65%2.76K | 173.56%1.28K | 4.25%491 | 4.47%491 |
| Change In working capital | 90.37%-13.83K | 109.33%4.77K | 17.03%81.41K | -84.94%50.24K | 117.23%16.71K | 59.80%-143.59K | -147.22%-51.09K | 200.11%69.56K | 866.05%333.55K | -200.05%-96.97K |
| -Change in receivables | 116.73%3.81K | 167.60%45.38K | 1,155.93%16.75K | -48.10%36.51K | 111.14%14.9K | -930.50%-22.77K | -376.90%-67.13K | 43.86%-1.59K | 12,867.70%70.35K | -346.20%-133.68K |
| -Change in prepaid assets | 102.07%6.48K | 48.40%-1.11K | -109.60%-6.31K | -97.85%5.99K | 5,527.18%312.06K | 8.18%-312.86K | -38.14%-2.16K | 1,227.90%65.7K | 3,897.12%278.64K | 2.81%-5.75K |
| -Change in payables and accrued expense | -112.56%-24.12K | -317.13%-39.5K | 1,203.07%70.97K | 150.15%7.74K | -830.67%-310.25K | 1,445.65%192.04K | -78.72%18.19K | -82.89%5.45K | -154.94%-15.44K | -12.52%42.46K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 44.72%-23.26K | -26.22%149.1K | -87.13%20.93K | -84.33%68.14K | 1,507.19%102.11K | 89.52%-42.08K | 224.03%202.09K | 294.54%162.64K | 1,296.31%434.78K | -71.09%6.35K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 41.08%-297.31K | 112.57%14.44K | 91.67%-32.49K | -2.7K | -276.56K | -504.64K | -114.82K | -389.82K | 0 |
| Net PPE purchase and sale | --0 | 41.08%-297.31K | 112.57%14.44K | 91.67%-32.49K | ---2.7K | ---276.56K | ---504.64K | ---114.82K | ---389.82K | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | 41.08%-297.31K | 112.57%14.44K | 91.67%-32.49K | ---2.7K | ---276.56K | ---504.64K | ---114.82K | ---389.82K | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | -30.20%349K | ||||||||
| Net common stock issuance | ---- | --0 | ---- | ---- | ---- | ---- | -30.20%349K | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | ---- | --0 | ---- | ---- | ---- | ---- | -30.20%349K | ---- | ---- | ---- |
| Net cash flow | ||||||||||
| Beginning cash position | -30.96%330.48K | 10.75%478.69K | 260.49%295.11K | 603.00%259.46K | 423.83%160.05K | 10.75%478.69K | 354.16%432.24K | 416.81%81.86K | -29.27%36.91K | 1.15%30.55K |
| Current changes in cash | 92.70%-23.26K | -419.05%-148.21K | -91.09%35.37K | -20.69%35.65K | 1,464.71%99.41K | 20.67%-318.64K | -86.22%46.45K | -4.70%396.83K | 223.70%44.96K | -71.09%6.35K |
| End cash Position | 91.95%307.22K | -30.96%330.48K | -30.96%330.48K | 260.49%295.11K | 603.00%259.46K | 423.83%160.05K | 10.75%478.69K | 10.75%478.69K | 416.81%81.86K | -29.27%36.91K |
| Free cash from | 92.70%-23.26K | 33.85%-200.14K | -134.64%-16.57K | -20.69%35.65K | 1,464.71%99.41K | 20.67%-318.64K | -85.68%-302.55K | 157.20%47.83K | 223.70%44.96K | -71.09%6.35K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.